Retained products of conception. Early fetal death with retention of dead fetus
Conditions
Interventions
Intervention 1: Methyleregonovine tablet 0/25 mg (TID for one week) with LD tablet (once in day for 21 days). Intervention 2: Methylergonovine tablet (0/25 mg TID for one week). Intervention 3: LD tab
Treatment - Drugs
Methyleregonovine tablet 0/25 mg (TID for one week) with LD tablet (once in day for 21 days)
Methylergonovine tablet (0/25 mg TID for one week)
LD tablet (once /day for 21 days)
Sponsors
Vice chancellor for Research, Shiraz University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
20 Years to 35 Years
Inclusion criteria
Inclusion criteria: Inclusion Criteria: woman with age between 20-35 first trimester abortion with bleeding or sonography that show retain tissue, HB 11 gr/dl or more, no history of angina, Myocardial infarction, Cardiovascular disease, Coronary artery disease, no history of Cerebrovascular Diseases, Transient ischemic attacks and Severe migraine, no history of Eclampsia and pre eclampsia, Severe hypertension, Peripheral arterial occlusive disease, no history of Thrombophlebitis and thromboembolic disorders, no history of Liver adenoma, Carcinoma or Benign tumors of the liver, Liver dysfunction and acute liver disease, No-smoking exclusion criteria: Unwillingness to cooperate, Allergic reactions to medicines, Hemoglobin decreased during the study (10 gr/dl or less)
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Complete pass of residual products of conception. Timepoint: After the intervention period. Method of measurement: Sonography. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactKhadijeh abdali
Fatemeh College of Nursing And Midwifery,Shiraz University of Medical Sciences
Outcome results
None listed